Course · Intro
How biotech and longevity work
What a gene actually is, how we read and rewrite it, how a drug is proven (and why most that work in a mouse fail in people), and what aging really is — so you can tell a real biotech or longevity claim from a sales pitch.
Biotech is the most over-promised corner of science. Headlines swing between miracle cures and doom, and almost all of it skips the one question that matters: has it been proven in actual people? This course takes the lid off the machine — what a cell, a gene, and a protein really are, how we read and edit the genome, how a drug is tested, and what aging actually is. Not a hype reel and not a doom story: the biology and the evidence, with the caveats kept intact.
What you'll be able to do
- Explain the machinery of life from first principles — the cell as a factory, DNA as a four-letter instruction set, and the central dogma by which a gene becomes a protein that does the actual work.
- Explain how we read the genome and rewrite it — what a genetic test can and can't tell you, how gene editing works and what it can't yet fix, and why a drug is a molecular key whose fit brings side effects with it.
- Judge medical evidence — why a result in a dish or a mouse is not a cure in a person, how a clinical trial and its control group settle the question, and how to read a risk number without being misled.
- Explain why we age and judge a longevity claim honestly — separating accumulated-damage biology from a single-clock myth, healthspan from lifespan, and a mechanism shown in mice from a benefit proven in people.
Course complete
You finished every lesson. Put your name on it.
Module 1 — The code of life
The cell, a tiny factory
Explain that every living body is made of cells, and that a cell is a self-running factory — it takes in materials, builds and ships products, powers itself, and follows instructions stored in its nucleus — so that 'how the body works' is, underneath, 'what cells do'.
DNA, the four-letter code
Explain that DNA is a long instruction set written in a four-letter alphabet, that the same complete genome sits in nearly every cell, that a gene is a stretch that spells out one job, and that cells differ (a liver cell vs a neuron) because they switch different genes on — not because they hold different DNA.
From gene to protein
Explain the central dogma in plain terms — a gene is copied into RNA, and the RNA is read to assemble a protein — and that proteins are the machines that actually do the work (enzymes, structure, signals), so 'a gene for X' really means 'a recipe for a protein that affects X'.
Module 2 — Reading it and rewriting it
Reading the genome
Explain what DNA sequencing does — spelling out the letters of a genome — why reading it has become cheap and fast, and the crucial caveat that a 'risk gene' shifts the odds rather than fixing your fate, so a genetic test reports probabilities, not destiny.
Rewriting the genome
Explain gene editing as a molecular find-and-replace — a guide locates a target sequence, the DNA is cut, and the cell's repair patches in a change — what it can plausibly fix (single-gene diseases) and why most traits and diseases, being the work of many genes plus environment, are far harder to edit.
Drugs as molecular keys
Explain that most medicines work by fitting a target molecule like a key in a lock — turning a process up or down — that side effects arise because the same key often fits other locks too, and that binding a target in a dish is only the start of the long road to helping a patient.
Module 3 — Proving it works
A dish is not a mouse is not a person
Explain the central caveat of the whole subject — that a result in cells or in a mouse usually does not carry over to humans, because people are more complex, slower, and more varied — so most promising compounds fail along the way, and 'it works in mice' is a beginning, not a finding.
How a clinical trial works
Explain the clinical-trial pipeline — phase 1 (is it safe?), phase 2 (is there a signal?), phase 3 (is it better than what we already have?) — and why the control group is the whole point: without comparing against a placebo or standard care, and without blinding, natural recovery and the placebo effect masquerade as the drug working.
Reading the result
Explain how to read a medical result without being misled — that 'cuts risk by half' can mean a fall from 2% to 1% (relative vs absolute risk), that a tiny study proves little, and that a correlation in observed data is not proof that one thing caused the other.
Approved is not the end
Explain that approval is a bet on averages from a few thousand people, that effects too rare to appear in a trial only surface once millions take a drug, and that 'works on average' is not 'works for you' — so monitoring continues after launch and an individual response can differ from the headline number.
Module 4 — Aging and the longevity question
Why we age
Explain that aging is not one clock running down but accumulated damage across several systems at once — cells stop dividing, DNA errors build up, molecular junk collects, repair slows — which is why there is no single 'aging gene' to switch off and why fixing one mechanism alone does not stop the whole process.
Lifespan versus healthspan
Explain the difference between lifespan (years alive) and healthspan (years in good health), why the interventions with real human evidence are mostly unglamorous, and why striking 'reverses aging in mice' results keep appearing yet keep failing to translate to people — connecting back to the dish-mouse-human filter.
Capstone: reading a biotech or longevity claim
Use the whole course to decode real-style biotech and longevity claims — separating a mechanism shown in a dish or mouse from a benefit proven in people, relative from absolute risk, a risk gene from destiny, and healthspan from lifespan — and telling a sound claim from a shaky one from an oversold one.